Solid Tumor Clinical Trials in Oklahoma City, Oklahoma

4 studies are recruiting for solid tumor in Oklahoma City, Oklahoma right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

    This is a Phase 1/2, first in human (FIH), open-label, multicenter study of BHV-1510 monotherapy and in Combination with Cemiplimab in participants with previously treated, advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Site-116, Oklahoma City, Oklahoma
    Locations
    17 in total
    Run by
    Biohaven Therapeutics Ltd.

    See if you can join NCT06384807 on ClinicalTrials.gov

  2. A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

    This phase 1 study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Stephenson Cancer Center, Oklahoma City, Oklahoma
    Locations
    15 in total
    Run by
    OnCusp Therapeutics, Inc.

    See if you can join NCT06234423 on ClinicalTrials.gov

  3. A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

    The purpose of this research is to test the effectiveness and safety of the study drugs (VS-6766 and defactinib), and see what effects (good and bad) these drugs have on the patients with endometrioid cancer, mucinous ovarian cancer, high-grade serous ovarian cancer, or solid gynecological cancer.

    Stage
    Phase 2
    Ages
    18 to 99
    Site
    Stephenson Cancer Center, Oklahoma City, Oklahoma
    Locations
    4 in total
    Run by
    University of Oklahoma

    See if you can join NCT05512208 on ClinicalTrials.gov

  4. First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.

    The purpose of this study is to determine the safety, blood concentrations and treatment effect of CRB-601 in combination with immunotherapy in patients who have advanced solid tumors (cancer) and have exhausted other therapeutic options.CRB-601 targets a protein called avb8 integrin which is expre…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    SCRI - OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma
    Locations
    26 in total
    Run by
    Corbus Pharmaceuticals Inc.

    See if you can join NCT06603844 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.